BioAge Labs, Inc. ($BIOA)
Filing Information
| Accession Number | 0001120478-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 3, 2026 |
| Document Date | Feb 1, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
7,082
Total Value
$15,509.58
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Feb 1, 2026 | Exercise/Conversion | 3,541 | $4.38 | $15,509.58 | 29,491 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Feb 1, 2026 | Exercise/Conversion | 3,541 | $0.00 | $0.00 | 162,917 | Direct | โ | View Details |